Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.20.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 14,490,941 $ 12,563,853
Investments 8,865,992
Prepaid expenses and other current assets 620,754 361,311
Total current assets 23,977,687 12,925,164
Property and equipment, net 432,403 523,677
Intangible assets, net 18,344 19,154
Other assets 67,403 64,242
Total assets 24,495,837 13,532,237
Current liabilities:    
Accounts payable 472,984 444,776
Accrued liabilities 1,039,262 916,692
Accrued payroll and other compensation 353,915 677,755
Current portion of note payable, net of debt discount and offering costs of $34,566 and $0 as of September 30, 2020 and December 31, 2019, respectively 470,434
Total current liabilities 2,336,595 2,039,223
Notes payable, net of current portion and net of debt discount and offering costs of $276,486 and $546,312 as of September 30, 2020 and December 31, 2019, respectively 3,121,014 3,356,188
Total liabilities 5,457,609 5,395,411
Stockholders’ equity:    
Preferred stock, $0.001 par value, Authorized 5,000,000 shares; No shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively
Common stock, $0.001 par value, Authorized 180,000,000 shares as of September 30, 2020 and 75,000,000 as of December 31, 2019; Issued and outstanding 57,963,409 shares as of September 30, 2020 and 43,069,418 as of December 31, 2019 57,963 43,069
Additional paid-in capital 83,530,601 61,087,082
Accumulated deficit (64,550,336) (52,993,325)
Total stockholders’ equity 19,038,228 8,136,826
Total liabilities and stockholders’ equity $ 24,495,837 $ 13,532,237